Coloplast A/S
CLPBF
$57.64
$0.360.62%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.36% | 6.10% | 5.08% | 6.54% | 7.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.36% | 6.10% | 5.08% | 6.54% | 7.68% |
| Cost of Revenue | 8.52% | 4.74% | 3.83% | 6.48% | 6.43% |
| Gross Profit | 8.29% | 6.76% | 5.68% | 6.56% | 8.30% |
| SG&A Expenses | 8.80% | 6.90% | 5.76% | 8.13% | 10.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -442.88% | -1,297.92% | -579.55% | -5.73% | 21.21% |
| Total Operating Expenses | 8.42% | 5.54% | 4.27% | 6.98% | 8.45% |
| Operating Income | 8.22% | 7.63% | 7.26% | 5.34% | 5.66% |
| Income Before Tax | -42.67% | -2.21% | -2.05% | -1.44% | 1.98% |
| Income Tax Expenses | -25.66% | 32.83% | 91.38% | 57.86% | 44.04% |
| Earnings from Continuing Operations | -49.92% | -14.53% | -26.86% | -17.58% | -9.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.92% | -14.53% | -26.86% | -17.58% | -9.31% |
| EBIT | 8.22% | 7.63% | 7.26% | 5.34% | 5.66% |
| EBITDA | 45.38% | 7.93% | 7.27% | 5.91% | 6.58% |
| EPS Basic | -49.97% | -14.68% | -27.03% | -18.34% | -11.42% |
| Normalized Basic EPS | 11.49% | 4.39% | 6.19% | -1.98% | 0.16% |
| EPS Diluted | -49.98% | -14.65% | -27.02% | -17.78% | -10.82% |
| Normalized Diluted EPS | 11.52% | 4.42% | 6.27% | -1.21% | 0.93% |
| Average Basic Shares Outstanding | 0.09% | 0.19% | 0.24% | 0.94% | 2.30% |
| Average Diluted Shares Outstanding | 0.07% | 0.16% | 0.17% | 0.17% | 1.52% |
| Dividend Per Share | 11.74% | 9.03% | 9.03% | 4.76% | 4.76% |
| Payout Ratio | 1.26% | 0.32% | 0.44% | 0.28% | 0.16% |